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Muscle in Patients with Chronic Venous Disease
M. Clarke Moloney,1* G.M. Lyons,2 P. Breen,2 P.E. Burke1 and P.A. Grace11Department of Vascular Surgery, Mid-Western Regional Hospital, and 2Biomedical Electronics Laboratory,
Department of Electronic and Computer Engineering, University of Limerick, Limerick, IrelandObjectives. The aim of this study was to explore the option of stimulating calf muscle contraction through externally
applied neuromuscular electrical stimulation (NMES) and to measure venous blood flow response to this stimulation.
Methods. Ten patients with class 6 chronic venous disease (CEAP clinical classification) were recruited. Measurements of
peak venous velocities in the popliteal vein were recorded by Duplex scanning in response to six test conditions; 1. Standing,
2. Voluntary calf muscle contraction, 3. Standing with NMES applied, 4. Standing with compression bandaging applied to
the leg, 5. Voluntary calf muscle contraction with compression bandaging applied to the leg, 6. Stationary with compression
bandaging applied to the leg and NMES applied. Comfort assessment was completed using visual analogue scales at each
test stage and on study completion each patient completed a short structured interview to determine comfort and
acceptability of NMES.
Statistical analyses were carried out using SPSS, Version 9. Non-parametric testing was used in all analyses using the
Wilcoxon Signed Ranks Test for paired samples.
Results. There was a significant increase in venous velocities on voluntary contraction of the calf muscle (median resting vel
7.3 cm/s; voluntary contraction median 70 cm/s) and with the introduction of NMES, both with compression (median
velocity 15 cm/s, pZ0.005 Wilcoxon) and without compression (median velocity 13 cm/s, pZ0.005 Wilcoxon). The
greatest increase with NMES was when combined with compression bandaging. All patients reported the stimulus as an
acceptable treatment option with 90% reporting NMES as comfortable.
Conclusions. Healing rates in venous ulceration with the application of compression bandaging remain between 50 and
70%. This study shows a positive haemodynamic response to NMES. Further research is needed to quantitatively measure
the effect of NMES on ulcer healing.Keywords: Venous ulceration; Haemodynamics; Electrical stimulation; Pain.Introduction
Chronic venous insufficiency (CVI) of the lower limbs
is frequently caused by failure of the calf muscle
pump; such failure occurs secondary to valve destruc-
tion in the deep leg veins. CVI can also be caused by
superficial vein reflux, or a combination of superficial
and deep reflux, all of which can lead to venous
hypertension resulting in leg ulceration. Compression
bandaging, which is currently the mainstay treatment
for venous ulcers, centres on reducing venous
hypertension by applying external pressure to aid
the calf muscle pump in assisting venous return.
Despite the application of compression bandaging,ing author. Mary Clarke Moloney, Department of
ery, Mid-Western Regional Hospital, Limerick, Ireland.
: mclarkemoloney@mwhb.ie
0300 + 06 $35.00/0 q 2005 Elsevier Ltd. All rights reserhealing rates remain disappointing at 50–70% after 12
weeks of treatment.1 There is an obvious need to
develop new treatment strategies, which might
improve healing rates.
Neuromuscular electrical stimulation (NMES)
refers to the application of pulses of electrical current,
delivered through surface electrodes, to trigger
generation of a neural action-potential-train to induce
an artificial muscle contraction.2 In a previous study
we showed that NMES applied to the gastrocnemius
muscle significantly increased venous blood flow
through the popliteal vein of healthy volunteers with
and without leg compression.3 However, no data exist
as to the efficacy of this potential treatment in patients
with venous leg ulceration. The present study, there-
fore, was undertaken to: 1. investigate the changes in
popliteal venous blood flow velocities in patients withEur J Vasc Endovasc Surg 31, 300–305 (2006)
doi:10.1016/j.ejvs.2005.08.003, available online at http://www.sciencedirect.com onved.
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mius muscle, 2. Compare the effect of NMES on
venous blood flow with and without compression
bandaging, 3. Assess the acceptability of NMES as a
treatment option for patients with venous ulcers.Methods
Ten patients classified as class-6 on the Clinical–
Etiology–Anatomy–Pathophysiology (CEAP) classifi-
cation system for chronic venous disorders consented
to participate in this study. Each patient attended the
hospital vascular laboratory for testing. Two round
(5 cm diameter) neurostimulation hypoallergenic skin
surface electrodes (PALSw Nidd Valley Medical) were
applied to the back of each patient’s calf and NMES
was applied (Fig. 1) as described previously by us.3Fig. 1. Placement of the electrodes. The cathode electrode
placed high on the calf, distally about 1.25 cm below the
proximal end of the muscle heads and the anode electrode
placed well above the Achilles tendon, towards the end of
the muscle belly.The choice of positioning of the electrodes was based
on a earlier study that established the pattern of
electrode positions that would produce the maximum
muscle contraction in response to electrical stimu-
lation.3 A BMR NeuroTech NT2000e (BMR Ltd,
Galway, Ireland) muscle stimulator was used to
stimulate the calf muscle. The stimulator was set to
deliver a pulse duration of 300 ms, a pulse frequency of
35 Hz, a contraction time of 2 s, a relaxation time of 6 s,
a ramp-up time of 0.5 s and a ramp-down time of 0.2 s;
we have previously shown that these parameters
produce the most efficient muscle contraction with
the minimum of discomfort.3,4
Prior to conducting the experiment, NMES was
applied for a period of 10 min to allow the subject to
become accustomed to the sensation of NMES.
Stimulation amplitude was gradually increased, the
patient was asked to report at what level they felt the
amplitude was uncomfortable (pain threshold) and at
what level the discomfort became unbearable (pain
tolerance level). For all test measurements, stimulus
amplitude was set just below the pain threshold level
for each individual patient.
Peak venous velocities in the popliteal vein were
measured using Doppler ultrasound as previously
described.3 The popliteal vein was identified and
measurements of peak venous velocities at each test
stage were taken in triplicate with the mean score
calculated. Six tests were performed in the following
order:
Test 1. Standing—the patient was in the upright
standing position. Venous flow velocities were
measured and three peak measurements recorded.
Test 2. Voluntary contraction—the patient changed
from the standing position to a ‘tip-toe’ position,
this movement causing an exaggerated calf muscle
contraction, peak velocities were recorded. This test
was repeated three times and the mean velocity
score calculated.
Test 3. Standing with NMES applied—the patient
resumed the standing position and NMES was
applied using the parameters already discussed.
NMES elicited a muscle contraction and the peak
velocity from each contraction was recorded, again
the mean score from three contractions was
calculated.
Test 4. Standing with compression bandaging—four
layer compression bandaging (Proforee) was
applied to the patients leg (from toe to below
knee) and Test 1 was repeated.
Test 5. Voluntary contraction with compression
bandaging—Test 2 was repeated with compression
bandaging.Eur J Vasc Endovasc Surg Vol 31, 3 2006
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NMES applied—Test 3 was repeated with com-
pression bandaging and NMES.
Comfort was assessed using a 100 mm, non-
hatched visual analogue scale (VAS) where the
patients were asked to mark the level of their pain
after each test.5,6 It was pre-defined that VAS pain
scores of 30 mm or less would be categorised as mild
pain, between 31 and 69 mm as moderate pain and
scores of 70 mm or greater as severe pain, as
categorised by Kelly (2001).7 The minimum clinically
significant difference (MCSD) in VAS scores was
calculated as an increase in scores between test stages
of 12 mm.7 At the end of the study each patient
completed a short structured interview during which
they were asked to give a verbal categorical rating of
the discomfort caused by NMES, as ‘very comfortable’,
‘comfortable’, ‘bearable’ or ‘unbearable’.They were
also asked to give a numerical rating of their
discomfort using a pain scale ranging from 1 (no
pain at all) to 10 (worst imaginable pain). Patients were
also asked if they would consider NMES an acceptable
treatment option if it were shown to promote ulcer
healing.
Statistical analyses were carried out using SPSS,
Version 9. Non-parametric testing was used in all
analyses using the Wilcoxon Signed Ranks Test for
paired samples. Results are given as medians and
range. A p value of !0.05 was considered statistically
significant.
Ethical approval was obtained from the Research
Ethics Committees at the Mid-Western Regional
Hospital, Limerick and at the University of Limerick.Results
The median (and range) results for all tests are given in
Table 1. There was no statistical difference in the
median popliteal vein venous velocity when patients
were standing without (Test 1) or with (Test 4)Table 1. Median score (and range) for peak venous velocities at each
Test
Stationary
Voluntary contraction
Stationary with NMES
Stationary with compression
Voluntary contraction with compression
NMES and compression
* p!0.005.
† p!0.005 vs Test 1, stationary (Wilcoxon).
‡ p!0.005.
§ p!0.005 vs Test 4, stationary with compression (Wilcoxon).
Eur J Vasc Endovasc Surg Vol 31, 3 2006compression (7.3 vs 5.8 cm/s, pO0.05). A voluntary
muscle contraction (Tests 2 and 5) showed approxi-
mately a 10-fold increase in blood flow over standing
both without (70 vs 7.3 cm/s, pZ0.005) and with
compression (73 vs 5.8 cm/s, pZ0.005).
The introduction of NMES produced a significant
increase in velocities (Table 1). There was a significant
82% increase in median venous velocity when NMES
was applied when patients were standing (Test 3)
compared to the median velocity during standing
without NMES or compression (Test 1) (13 vs 7.3, pZ
0.005). This increase was also significant when
compression and NMES were combined (Test 6)
compared to standing with compression (Test 4) (15
vs 5.8 cm/s, pZ0.005). There was no statistical
difference in the median velocity when NMES was
applied without (Test 3) or with (Test 6) compression
(13 vs 15 cm/s, pZ0.88).
Visual analogue scale scores from each patient
compared comfort levels without NMES and with
NMES at all test stages. Baseline stationary VAS
categorical scores in Test 1 without stimulation
indicated mild pain in eight patients and moderate
in two. When NMES was applied in Test 3 VAS
categorical scores remained unchanged in nine
patients with one patient reporting an increase from
mild to moderate pain. This patient’s increased VAS
score was greater than the MCSD with a reported
increase of 33 mm. (Table 2 for individual VAS scores).
Baseline scores in Test 4 (stationary with compression)
reported mild pain in eight patients, moderate in two.
When NMES was applied (Test 6) pain increased in
two patients from mild to moderate (Table 2). MCSD in
VAS scores between Tests 4 and 6 was recorded in two
patients with increased scores of 25 and 38 mm
(Table 3). The numerical pain score at the end of the
study period showed a mean score of 2.3 (SD 1.3). Two
patients reported the use of NMES as ‘very comfor-
table’, seven as ‘comfortable’, and one as ‘bearable’.
All 10 patients stated that they would find NMES
acceptable as a treatment.test stage
Median (range) peak venous velocity (cm/s) in the popliteal vein
7.3 (4.0–15)
70* (29–206)
13† (9.4–27)
5.8 (3.0–14)
73‡ (27–213)
15§ (7.2–49)
Table 2. VAS scores, pain category and the difference in scores between Test 1 (standing) and Test 3 (standing with NMES applied)
Patient No. VAS scores (mm)
Test 1
Pain category VAS scores (mm)
Test 3 (NMES)
Pain category Difference in VAS
scores (mm)
1 20 Mild 20 Mild 0
2 10 Mild 15 Mild 5
3 33 Moderate 40 Moderate 7
4 15 Mild 20 Mild 5
5 3 Mild 4 Mild 1
6 4 Mild 9 Mild 5
7 10 Mild 21 Mild 11
8 45 Moderate 45 Moderate 0
9 3 Mild 5 Mild 2
10 30 Mild 63 Moderate 33 (OMCSD)
No compression applied.
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In this study we have shown that the application of
NMES to the gastrocnemius muscle significantly
increases standing popliteal venous blood flow in
patients with venous ulceration. However, this
increase was only one tenth the increase induced by
a voluntary contraction of the calf muscles. Com-
pression had no significant impact on venous blood
flow and 90% of our patients found NMES comfor-
table; all considered it acceptable as a potential
treatment for venous ulcers.
The significant finding from this study is the
increase in venous velocities produced by the appli-
cation of NMES; 82% without compression (Test 3) and
155% with compression (Test 6) compared to baseline
stationary results (Tests 1 and 4, respectively).
Although we did not measure venous pressure
directly in our study, we speculate that NMES by
increasing popliteal venous blood flow may reduce
venous hypertension in patients with venous ulcera-
tion. Treatment with NMES might be of greatest value
in immobile or reduced mobility patients with venous
ulceration who do not use their calf muscle pump
optimally. As increased blood flow velocities of 82–
155% can be elicited using NMES while patients areTable 3. VAS scores, pain category and the difference in scores betw
compression and NMES applied)
Patient No. VAS scores (mm)
Test 4
Pain category
1 20 Mild
2 10 Mild
3 29 Mild
4 10 Mild
5 2 Mild
6 10 Mild
7 20 Mild
8 45 Moderate
9 8 Mild
10 31 Moderateimmobile, NMES may thus be used to artificially
increase the levels of calf muscle activity towards
normal to improve venous return and reduce venous
pressure.
In our study, very large increases in blood flow
velocities were achieved during voluntary calf con-
traction as seen in Tests 2 and 5. We believe that these
results reflect the inseparable and very important link
between the ankle joint and the calf muscle pump.
These test stages (2 and 5) involved a heel lift motion
resulting in exaggerated planter flexion and maximum
voluntary calf muscle contraction. The results empha-
sis the importance of ankle exercises which assist
contraction of the calf muscle thereby accelerating
venous return. The blood flow velocities generated
from voluntary calf muscle contraction seen in Tests 2
and 5, could not practically be artificially generated by
NMES; multi-site stimulation would be required to
selectively stimulate both the soleus and gastrocne-
mius muscles and the stimulation intensity levels
required to generate such a contraction using surface
NMES would be uncomfortable for the patient.
The importance of ankle movement in promoting
venous flow has been identified in this and other
studies,8,9 however, ankle arthropathy due either to
venous hypertension or other medical conditions sucheen Test 4 (standing with compression) and Test 6 (standing with
VAS scores (mm)
Test 6 (NMES)
Pain category Difference in VAS
scores (mm)
20 Mild 0
15 Mild 5
40 Moderate 11
35 Moderate 25 (OMCSD)
5 Mild 3
16 Mild 6
26 Mild 6
45 Moderate 0
10 Mild 2
69 Moderate 38 (OMCSD)
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mobility in a number of patients, thereby reducing the
effect ankle joint movements may have in promoting
venous return. Dix et al. (2003)10 investigated the
relationship between clinical severity of venous
disease, calf muscle pump dysfunction and range of
ankle movements. Dix’s observed a reduced range of
ankle movements in patients with primary varicose
veins, which was inversely proportional to the severity
of venous disease. He concluded that calf muscle
pump dysfunction is associated with reduced range of
ankle movements. In addition, reduced ankle mobility
has been shown to be a risk factor for slow rates of
ulcer healing.11 Barwell et al. (2001)11 reported only
13% of chronic venous ulcers healed in patients with
less than 358 ankle mobility after 24 weeks of
treatment, compared to 60% healed in patients with
greater than 358 of mobility. NMES may prove a useful
adjunct in the treatment of those patients with reduced
range of ankle movements. It is our opinion that
NMES is capable of producing calf muscle contrac-
tions without the action of the ankle joint and,
therefore, may help to compensate for the reduced
effectiveness of the ankle joint by generating artificial
calf muscle contractions.
The findings from this study indicate the potential
benefit of using NMES to improve venous return.
However, there was no significant difference in venous
velocities with the introduction of compression in
Tests 4–6. This is surprising, as one may reasonably
expect greater velocities in a limb when compression
has been applied. In our earlier study which looked at
the response of healthy subjects to NMES, we noted
significantly increased velocities when compression
hosiery was applied in conjunction to NMES.3
However, the previous study differs from this study
in that its subjects were very fit healthy young adults
with no evidence of venous disease. A possible
explanation for the lack of venous velocity increase
with compression in the current study is that all
patients had chronic venous disease and compression
was applied after the patient had participated in
voluntary muscle contractions (Test 2) and NMES
induced muscle contractions (Test 3). Thus, the
volume of pooled blood available to respond to a
contraction would have been reduced and random
sequencing of tests might have been preferable.
Surface NMES has many existing uses in medicine,
however, discomfort has been identified as a factor
which limits its use.12 Surface NMES involves
stimulation of neuromuscular structures, which inad-
vertently results in activation of sensory receptors
on the skin surface. This acute sensory excitation
can cause discomfort. To minimise discomfortEur J Vasc Endovasc Surg Vol 31, 3 2006the stimulation parameters chosen for this study
were previously shown to be most effective and
cause least discomfort.3,13,14 The results from the
various pain assessment tools used indicated that
most patients found NMES comfortable with minimal
increase in pain scores with the application of NMES,
indicating that the parameters chosen may be appro-
priate for this population group.Conclusion
The results from this study show a beneficial
haemodynamic response to NMES. NMES may
prove useful in the treatment of patients with venous
ulceration who have reduced mobility or reduced
ankle range of movements. NMES was perceived by
all trial patients to be an acceptable treatment for
venous ulcers, which did not cause extra discomfort.
However, this study did not apply NMES at a
therapeutic level and greater research needs to be
carried out to investigate the effect of NMES on
healing rates compared to current best practise.Acknowledgements
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